Saichao He

Title: Saichao He: Innovator in Gene Therapy

Introduction

Saichao He is a prominent inventor based in Beijing, China. He has made significant contributions to the field of gene therapy, particularly in the treatment of retinal diseases. His innovative work has led to the development of a unique vector that holds promise for treating Bietti's crystalline dystrophy.

Latest Patents

Saichao He holds a patent for a vector and method for treating Bietti's crystalline dystrophy. The patent describes a vector comprising a polynucleotide encoding CYP4V2 and a promoter operably linked to this polynucleotide. This vector demonstrates a good expression effect, high expression speed, and stable expression intensity. The application also includes cells, pharmaceutical compositions, and kits that utilize the vector, along with methods for treating, alleviating, and preventing diseases associated with retinal pigment epithelium (RPE) atrophy. He has 1 patent to his name.

Career Highlights

Saichao He is associated with Chigenovo Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for retinal disorders.

Collaborations

He has collaborated with notable colleagues, including Liping Yang and Shaohong Chen, to further enhance the impact of his research.

Conclusion

Saichao He is a key figure in the field of gene therapy, with his innovative approaches paving the way for new treatments for retinal diseases. His contributions are vital to the advancement of medical science and patient care.